1.
Morie A. Gertz, Martha Q. Lacy, John A. Lust, Philip R. Greipp, Thomas E. Witzig, Robert A. Kyle. Long-term risk of myelodysplasia in melphalan-treated patients with immunoglobulin light-chain amyloidosis. haematol [Internet]. 2008Aug.29 [cited 2024May25];93(9):1402-6. Available from: https://haematologica.org/article/view/5004